227 related articles for article (PubMed ID: 25885317)
1. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
Chang HC; Cho CY; Hung WC
Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
[TBL] [Abstract][Full Text] [Related]
3. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
Chang HC; Liu LT; Hung WC
Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608
[TBL] [Abstract][Full Text] [Related]
4. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.
Hsu MC; Chang HC; Hung WC
J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
Lee KJ; Lee KY; Lee YM
Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
[TBL] [Abstract][Full Text] [Related]
6. SUMO-1 overexpression increases RbAp46 protein stability and suppresses cell growth.
Giri R; Yeh HH; Wu CH; Liu HS
Anticancer Res; 2008; 28(6A):3749-56. PubMed ID: 19189660
[TBL] [Abstract][Full Text] [Related]
7. Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells.
Qi Q; Lu N; Li C; Zhao J; Liu W; You Q; Guo Q
Mol Carcinog; 2015 Jun; 54 Suppl 1():E13-25. PubMed ID: 24532189
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK.
Chiang CH; Hou MF; Hung WC
Biochim Biophys Acta; 2013 Apr; 1830(4):3067-76. PubMed ID: 23333633
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
[TBL] [Abstract][Full Text] [Related]
11. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
Wang CH; Chang HC; Hung WC
J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene.
Sasahara RM; Brochado SM; Takahashi C; Oh J; Maria-Engler SS; Granjeiro JM; Noda M; Sogayar MC
Cancer Detect Prev; 2002; 26(6):435-43. PubMed ID: 12507228
[TBL] [Abstract][Full Text] [Related]
13. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
14. Attenuated expression and function of the RECK tumor suppressor under hypoxic conditions is mediated by the MAPK signaling pathways.
Jeon HW; Lee KJ; Lee SH; Kim WH; Lee YM
Arch Pharm Res; 2011 Jan; 34(1):137-45. PubMed ID: 21468925
[TBL] [Abstract][Full Text] [Related]
15. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
16. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
17. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.
Clark JC; Thomas DM; Choong PF; Dass CR
Cancer Metastasis Rev; 2007 Dec; 26(3-4):675-83. PubMed ID: 17828469
[TBL] [Abstract][Full Text] [Related]
18. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ha-rasval12 on nm23 expression, tumor formation and metastasis of the transformants, and immunomodulation in tumor-bearing mice.
Hsieh CC; Wu SY; Lan SH; Weng TY; Tsai Y; Liu HS
Anticancer Res; 2010 Sep; 30(9):3585-92. PubMed ID: 20944141
[TBL] [Abstract][Full Text] [Related]
20. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.
Chang CK; Hung WC; Chang HC
J Cell Mol Med; 2008 Dec; 12(6B):2781-9. PubMed ID: 18194466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
